Baxter
BAX
#1265
Rank
$15.39 B
Marketcap
$29.99
Share price
0.64%
Change (1 day)
-12.54%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

EPS for Baxter (BAX)

EPS in 2025 (TTM): -$0.03000

According to Baxter's latest financial reports the company's current EPS (TTM) is -$0.03000. In 2023 the company made an earnings per share (EPS) of $5.24 an increase over its 2022 EPS that were of -$4.83.

EPS history for Baxter from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.03000
2023$5.24-208.49%
2022-$4.83-288.67%
2021$2.5618.52%
2020$2.16
2018$3.04130.3%
2017$1.32
2015$1.77-61.48%
2014$4.6024.32%
2013$3.70-12.32%
2012$4.227.93%
2011$3.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Cardinal Health
CAH
$6.43-21,533.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
$7.49-25,066.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
$1.38-4,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$5.25-17,600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
$3.85-12,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$17.09-57,066.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
-$4.75 15,733.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$3.30-11,100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ICU Medical
ICUI
-$3.83 12,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA